Already a member? Sign in
Category: Prescription Drugs
Most Popular Types: Detrol LA, Detrol, Detrusitol
Generic Name: Tolterodine
Tolterodine is an anticholinergic agent used for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency, or urge incontinence.
| Purpose | # of patients |
# of patients with evaluations
Efficacy
|
Major | Moderate | Slight | None | Can’t tell |
|---|---|---|---|---|---|---|---|
| Bladder problems | 226 | 57 |
|
|
|
|
|
| Other | 27 | 3 |
|
|
|
||
| Neurogenic bladder | 12 | 2 |
|
|
|||
| Urinary Incontinence | 11 | 4 |
|
|
|
||
| Incontinence | 11 | 5 |
|
|
|
|
|
| Urinary frequency | 8 | 4 |
|
|
See all 244 patients currently taking Tolterodine
Mouse over the table for more information
Commonly reported side effects, conditions, and hospitalizations associated with Tolterodine
| Dry mouth (xerostomia) | 17 | |
|---|---|---|
| Dry eyes | 3 | |
| Constipation | 2 | |
| Difficulty urinating occasionally | 2 | |
| Hospitalization | 2 | |
| Pain in lower abdomen | 1 | |
| See all 14 reported side effects ▼ | ||
Frequently reported dosages based on patients currently taking Tolterodine. See all 18 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Did not seem to work | 49 | ||
| Doctor's advice | 28 | ||
| Other | 26 | ||
| Expense | 12 | ||
| Side effects too severe | 9 | ||
| Course of treatment ended | 9 | ||
| Change in health plan coverage | 8 | ||
| Personal research | 4 |
Adherence
Taking treatment as prescribed
Adherence of Tolterodine
Always |
73 | 87% |
|
|---|---|---|---|
Usually |
6 | 7% |
|
Sometimes |
0 | 0% |
|
Never |
5 | 6% |
|
Burden
Difficulty being on treatment
Burden of Tolterodine
Very |
2 | 2% |
|
|---|---|---|---|
Somewhat |
1 | 1% |
|
A little |
13 | 15% |
|
Not at all |
68 | 81% |
|
Cost
Paid out of pocket
Cost of Tolterodine
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
7 | 13% |
|
$25-49 |
22 | 42% |
|
< $25 |
23 | 44% |
|
See more information, including instructions, precautions, side effects, and interactions.
Report created on May 27, 2012.